Sarissa Capital Offshore Master Fund LP's Net Worth
$0
Who is Sarissa Capital Offshore Master Fund LP?
Sarissa Capital Offshore Master Fund LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include VIVUS INC, APRICUS BIOSCIENCES, INC., Iterum Therapeutics plc, and Regulus Therapeutics Inc..
SEC CIK
Sarissa Capital Offshore Master Fund LP's CIK is 0001577530
Past Insider Trading and Trends
2020 was Sarissa Capital Offshore Master Fund LP's most active year for disposing of shares, totalling 3 transactions. Sarissa Capital Offshore Master Fund LP's most active month to dispose stocks was the month of March. In 2020 Sarissa Capital Offshore Master Fund LP cashed out on 81,667 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VIVUS INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
APRICUS BIOSCIENCES, INC. (SEEL) Snapshot price: $0.2305
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
| +0.42% | 6.1K |
$1.63 | $9,949.52 | 1.45M |
Aug 31
| |||
Form 4
| +84.89% | 6.65M |
$0.88 | $5,850,000.64 | 14.48M |
Mar 3
| |||
Form 4
| +20.03% | 1.31M |
$0.88 | $1,150,000.72 | 7.83M |
Jan 12
| |||
| No matching records found | |||||||||
Iterum Therapeutics plc (ITRM) Snapshot price: $1.12
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$2.43 | -$50,007,284.23 | 20.62M |
Feb 11 - Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||